Evidence map›Paper›PMID 38092052›Full record

ArticleBioinformatics (Oxford, England)2023

Benchmarking and improving the performance of variant-calling pipelines with RecallME.

Gianluca Vozza, Emanuele Bonetti, Giulia Tini, Valentina Favalli, Gianmaria Frigè, Gabriele Bucci, Simona De Summa, Mario Zanfardino, Francesco Zapelloni, Luca Mazzarella

Open access · goldAbstract read
PubMed Publisher
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Gianluca VozzaDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Emanuele BonettiDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Giulia TiniDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-2616-3962
Valentina Favalli4bases SA, Manno, Ticino, Switzerland.ORCID 0000-0002-7058-6479
Gianmaria FrigèDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-3253-7091
Gabriele BucciCenter for Omics Sciences, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.ORCID 0000-0001-9838-7204
Simona De SummaMolecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori, "Giovanni Paolo II", Bari, Italy.
Mario ZanfardinoIRCCS Synlab SDN, 80143, Naples, Italy.
Francesco Zapelloni4bases SA, Manno, Ticino, Switzerland.ORCID 0000-0001-9127-037X
Luca MazzarellaDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-4043-3279
European Institute of Oncology · ITUniversity of Milan · ITIRCCS Ospedale San Raffaele · ITIstituto Tumori Bari · IT

Funding

Italian Ministry of Health
6 · The paper itself

Abstract

motivationThe steady increment of Whole Genome/Exome sequencing and the development of novel Next Generation Sequencing-based gene panels requires continuous testing and validation of variant calling (VC) pipelines and the detection of sequencing-related issues to be maintained up-to-date and feasible for the clinical settings. State of the art tools are reliable when used to compute standard performance metrics. However, the need for an automated software to discriminate between bioinformatic and sequencing issues and to optimize VC parameters remains unmet.

resultsThe aim of the current work is to present RecallME, a bioinformatic suite that tracks down difficult-to-detect variants as insertions and deletions in highly repetitive regions, thus providing the maximum reachable recall for both single nucleotide variants and small insertion and deletions and to precisely guide the user in the pipeline optimization process. AVAILABILITY AND IMPLEMENTATION: Source code is freely available under MIT license at https://github.com/mazzalab-ieo/recallme. RecallME web application is available at https://translational-oncology-lab.shinyapps.io/recallme/. To use RecallME, users must obtain a license for ANNOVAR by themselves.

Indexed as

BenchmarkingSoftwareComputational BiologyExomeHigh-Throughput Nucleotide Sequencing

Identifiers

PMID38092052
OpenAlexW4389668991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.